Revenue
$198.00K
Fiscal year ended 2019-12-31Operating income
-$24.89M
Fiscal year ended 2019-12-31Free cash flow
-$24.85M
Fiscal year ended 2019-12-31WINDTREE THERAPEUTICS INC /DE/ (WINT) reported revenue of $198.00K and net income of -$27.48M for the fiscal year ended 2019-12-31. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from WINDTREE THERAPEUTICS INC /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).
Income
| Metric | 2019-12-31 |
|---|---|
| Revenue | $198.00K |
| Cost of revenue | Unavailable |
| Gross profit | Unavailable |
| Operating income | -$24.89M |
| Net income | -$27.48M |
| Research & development | $12.69M |
| Weighted-average diluted shares | Unavailable |
| Pretax income | Unavailable |
| Income tax expense | Unavailable |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $12.40M |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2019-12-31 |
|---|---|
| Cash & equivalents | $22.58M |
| Total assets | $118.98M |
| Current assets | $23.86M |
| Total liabilities | $44.04M |
| Current liabilities | $7.82M |
| Total equity incl. NCI | $74.94M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | Unavailable |
| Accounts receivable | Unavailable |
| Goodwill | $15.68M |
| Long-term debt | Unavailable |
| Accounts payable | $1.71M |
Cash flow
| Metric | 2019-12-31 |
|---|---|
| Operating cash flow | -$24.66M |
| Capital expenditures | $191.00K |
| Investing cash flow | $13.80M |
| Financing cash flow | $21.77M |
| Net change in cash | $11.37M |
| Stock-based compensation | Unavailable |
| Common dividends paid | Unavailable |
| Common share repurchases | Unavailable |
| Depreciation & amortization | Unavailable |
Derived
| Metric | 2019-12-31 |
|---|---|
| Free cash flow | -$24.85M |
| Gross margin | Unavailable |
| Operating margin | -12572.2% |
| FCF margin | -12552.5% |
| SBC / revenue | Unavailable |
| Current ratio | 3.05x |
| Revenue YoY growth | -88.9% |
| Net margin | -13876.3% |
| R&D / revenue | 6407.6% |
| CapEx / revenue | 96.5% |
| Long-term debt / equity | Unavailable |
| Effective tax rate | Unavailable |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open WINT in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2025-11-19View SEC filing
10-Q · Filed 2025-08-19View SEC filing
10-Q · Filed 2025-05-15View SEC filing
10-K · Filed 2025-04-15View SEC filing
10-Q · Filed 2024-11-26View SEC filing
10-Q · Filed 2024-08-19View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.